Shalini Adnani’s debut feature 'Our Share of Sand' turns a diasporic gaze into an autocritique of pervasive structures.
Paradigm has raised $1.2 billion for a new venture fund, giving one of crypto's most prominent investment firms fresh capital as it expands into artificial intelligence, robotics and other frontier ...
Crypto VC firm Paradigm has raised $1.2 billion — its third venture fund and fourth overall — with the aim of investing in the “technical frontier,” the firm’s founder Matt Huang announced Wednesday.
Can you explain object-oriented programming to me like I'm 5 years old? Probably not. But here's a straightforward explanation of what OOP is ... Use Spring MVC MultipartFile, Java Path APIs and the ...
Gil Harari and Jonathan Silverman have rejoined Paradigm to lead a new Physical Production department, marking a full-circle moment for the pair, amid the agency’s expansion in below-the-line ...
Following the most recent Teenage Mutant Ninja Turtles release, the next Magic: The Gathering set returns to one of its own beloved worlds. Secrets of Strixhaven brings players back to the magical ...
Photo: Edgar Bernard, Inmaculada Fortanet, Noelia Ruiz i Julia Valeiras. The Research Group on Academic and Professional English at the Universitat Jaume I (GRAPE-UJI) is developing a computer tool to ...
Paradigm, one of the largest venture investors focused on crypto, is expanding its brief to include artificial intelligence, robotics and other forms of frontier-tech, according to people familiar ...
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Paradigm (“Paradigm” or the “Company”), a specialty care management organization focused on delivering solutions that improve outcomes for individuals with ...
Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also announcing a deal to acquire Flatiron Health's clinical research business unit. With the ...
Matthew Herper covers medical innovation — both its promise and its perils. When people talk about using artificial intelligence to transform the way medicines are studied, they often imagine ...